Related Experiment Video
Updated: Oct 31, 2025

06:40
Biofunctionalization of Magnetic Nanomaterials
Published on: July 16, 2020
2.8K
Multifunctional antibody-conjugated coiled-coil protein nanoparticles for selective cell targeting
Marcos Gil-Garcia1, Salvador Ventura1
1Institut de Biotecnologia i de Biomedicina and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona 08193, Spain.
Acta Biomaterialia
|June 30, 2021
Summary
This study developed novel protein nanoparticles from bacterial inclusion bodies, enabling noncovalent antibody attachment for targeted bioimaging and immunotherapy applications.
Area of Science:
- Biotechnology
- Nanomedicine
- Immunology
Background:
- Antibody-decorated nanostructures are crucial for bioimaging and therapeutics.
- Covalent antibody conjugation methods often impair antibody functionality.
- Bacterial inclusion bodies (IBs), typically waste, have potential but face limitations due to their amyloid-like nature.
Purpose of the Study:
- To engineer protein-based nanoparticles for stable, noncovalent antibody attachment.
- To create functional, non-amyloid inclusion bodies (IBs) for biomedical applications.
- To develop a versatile platform for antibody-directed cell targeting and immunotherapy.
Main Methods:
- Engineered α-helix-rich inclusion bodies (IBs) utilizing coiled-coil self-assembly.
- Created spherical, submicrometric, fluorescent, and biocompatible protein nanoparticles.
- Demonstrated high-affinity antibody capture and controlled decoration with multiple antibodies.
Main Results:
- Successfully produced functional, non-amyloid, fluorescent protein nanoparticles.
- Showcased the nanoparticles' capability for antibody-directed cell targeting.
- Constructed a bispecific antibody mimic for targeted T lymphocyte redirection to cancer cells.
Conclusions:
- Developed an easy, cost-effective strategy for producing traceable, multivalent protein nanostructures.
- Demonstrated the potential of these functional IBs as platforms for bioimaging and immunotherapy.
- Created a novel bispecific antibody mimic capable of simultaneously targeting two cell types.

